Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
All articles — 32010 total
Short sellers are on the move. Data as of August 27 shows meaningful shifts across biotech, tech, and beyond. CAPR (Capricor Therapeutics) leads the weekly movers. SI % of free float jumped to 45.6%, up from 36.4% just…
AutoZone heads into its September 1 fiscal Q4 earnings report with options traders more cautious than usual, even as short sellers continue to reduce positions. The clearest pre-earnings signal is in the options…
Options flow this week tells a split story. Semis are pulling in positive bets. Beaten-down names are attracting heavy put interest. NVDA topped the positive options bets leaderboard over the past seven days. The chip…
Bears stepped up pressure across biotech and marketing tech this week. CAPR short interest hit 45.6% of free float, up 9.2 percentage points in seven days. KVYO shorts nearly doubled, rising from 13% to 19.9% of FF.…
Workday dominated analyst desks Friday. Freedom Broker downgraded the enterprise software firm from Buy to Hold. The target dropped from $200 to $180. Consensus now shows 22 sell-side analysts with a bearish lean.…
Insider filings this week reveal a clear split: some executives are buying aggressively into weakness, while one founder is cashing out at scale. The most eye-catching sale came from NSSC. Richard Soloway, the founder…
Short interest shifted sharply across several sectors this week. Data from ORTEX as of August 27 shows clear trends — bears piled into biotech and marketing tech, while covering in others. CAPR saw the biggest weekly…
The biggest money flow story this week is a sharp reversal in U.S. equity sentiment. U.S.-focused ETFs posted a net outflow of $12.1B over the past week. That stands in stark contrast to the 3-month trend, where U.S.…
The lending market for GPRK just flipped dramatically. Availability collapsed to 58% overnight — down from 200% the day prior — as the borrow pool dried up and cost to borrow surged 146% in a week. At the same time,…
Markets are navigating a busy stretch. The S&P 500 and Nasdaq slipped as a chip stock rebound ran out of steam. European stocks have been volatile. Defense names in Europe got a lift after Ukraine ratified a $105…
Three major tech names hit the earnings calendar this week. The action peaks on Tuesday, September 1st. DELL reports after the close on Tuesday. Markets will watch closely for AI server demand signals. Dell's…
WDAY is drawing conflicting analyst views. Freedom Broker cut its rating to Hold from Buy today, slashing its target to $180 from $200. Yet Wells Fargo and UBS both lifted their targets on the same day. Wells Fargo…
Bill Gates has been quietly building a massive position in RSG. Filings disclosed this week show he spent $562 million buying Republic Services shares between August 10 and August 25. That's 2.57 million shares at an…
Short sellers have been busy in the past seven days. Three names stand out for big moves in the latest ORTEX data through August 27. CAPR — Capricor Therapeutics — saw the sharpest weekly jump. Short interest as a % of…
SoFi Technologies heads into the final days of August with a notably cleaner setup than last week's note described: the options alarm that dominated the August 19 article has unwound almost entirely, short sellers are…
CD Projekt Red enters its September 2 results in an unusual position: the ORTEX short score has jumped sharply over the past week, yet the lending market tells a completely different story — borrow remains loose, costs…
Central Garden & Pet heads into the final week of August with a sharp and accelerating build in short positions, options traders at their most defensive all year, and a stock that has barely moved — a combination that…
Rabigh Refining and Petrochemical Company heads into the final days of August with an interesting reversal: the stock has given back ground this week — down 3.6% to SAR 17.35 — even as the borrow market continues to…
WEN has given back a chunk of its August gains in a single week, dropping 11% to $7.82 as the call-heavy options positioning that defined the prior two weeks has collapsed to its most extreme bullish reading yet — a…
Disc Medicine heads into the final week of August with a striking disconnect: the stock has climbed 11% over the past month while the CEO has been consistently selling into that strength. The insider angle is the most…
